全文获取类型
收费全文 | 3044篇 |
免费 | 135篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 14篇 |
妇产科学 | 23篇 |
基础医学 | 241篇 |
口腔科学 | 761篇 |
临床医学 | 244篇 |
内科学 | 692篇 |
皮肤病学 | 30篇 |
神经病学 | 199篇 |
特种医学 | 144篇 |
外科学 | 278篇 |
综合类 | 189篇 |
预防医学 | 116篇 |
眼科学 | 10篇 |
药学 | 173篇 |
中国医学 | 28篇 |
肿瘤学 | 39篇 |
出版年
2024年 | 4篇 |
2023年 | 94篇 |
2022年 | 72篇 |
2021年 | 140篇 |
2020年 | 106篇 |
2019年 | 253篇 |
2018年 | 278篇 |
2017年 | 141篇 |
2016年 | 83篇 |
2015年 | 66篇 |
2014年 | 206篇 |
2013年 | 178篇 |
2012年 | 99篇 |
2011年 | 127篇 |
2010年 | 85篇 |
2009年 | 102篇 |
2008年 | 91篇 |
2007年 | 142篇 |
2006年 | 72篇 |
2005年 | 78篇 |
2004年 | 65篇 |
2003年 | 39篇 |
2002年 | 15篇 |
2001年 | 25篇 |
2000年 | 19篇 |
1999年 | 20篇 |
1998年 | 18篇 |
1997年 | 15篇 |
1996年 | 9篇 |
1995年 | 4篇 |
1994年 | 7篇 |
1993年 | 31篇 |
1992年 | 12篇 |
1991年 | 12篇 |
1990年 | 8篇 |
1989年 | 12篇 |
1988年 | 4篇 |
1985年 | 44篇 |
1984年 | 55篇 |
1983年 | 29篇 |
1982年 | 56篇 |
1981年 | 26篇 |
1980年 | 22篇 |
1979年 | 24篇 |
1978年 | 42篇 |
1977年 | 13篇 |
1976年 | 21篇 |
1975年 | 46篇 |
1974年 | 40篇 |
1973年 | 37篇 |
排序方式: 共有3192条查询结果,搜索用时 843 毫秒
41.
42.
43.
44.
Ileana L. Piña Katherine E. Di Palo Hector O. Ventura 《Journal of the American College of Cardiology》2018,71(20):2346-2359
This review discusses common mental health disorders and their associations with cardiovascular disease risks. Commonly found mental health disorders include depression, anxiety, and personality types. The link between depression and cardiovascular disease mortality has been established. Depression is also common in patients with heart failure. In addition to discussing psychological disorders, a review of psychotropic drugs is also included. Drugs are described for therapy for depression and anxiety, as well as associations with cardiovascular drug-drug interactions. Drug-drug interactions are more common and potentially dangerous in elderly patients, in whom the conditions often coexist. The most common drug-drug interactions involve the P450 system of enzymes. 相似文献
45.
46.
《Clinical and experimental hypertension (New York, N.Y. : 1993)》2013,35(11):1597-1618
The intravenous injection of an ED50 natriuretic dose (1 μg) of synthetic ANF decreases blood pressure by 61 ± 6 mmHg in 2-K, 1-C, and of 45 ± 6 mmHg in 1-K, 1-C hypertensive rats, which was positively correlated with its initial level only in the 2-K, 1-C group. The hypotensive response lasted longer in the latter (> 40 min) than in normotensive sham-operated rats. No difference in duration was seen between 1-K, 1-C hypertensive and its uninephrectomized normotensive controls. The diuretic response to ANF was higher in 2-K, 1-C rats. No hematocrit changes were observed in any group. ANF induced a rise in urinary kallikrein in all groups but the 1-K, 1-C. Urinary kallikrein excretion was positively correlated with natriuresis in normotensive but not in hypertensive groups. ANF induced an increase in urinary cGMP excretion in all groups but the 1-K, 1-C, and an increase in plasma cGMP in the normotensive sham-operated animals.Our results suggest that the fall in blood pressure induced by synthetic ANF could be due to vasodilatation, a drop in cardiac output cannot, however, be eliminated. Whether the hypotensive effect of ANF is mediated by cGMP remains to be demonstrated. 相似文献
47.
48.
49.
《Vaccine》2015,33(2):367-373
BackgroundIn 2013–2014 Greece experienced a resurgence of severe influenza cases, coincidental with a shift to H1N1pdm09 predominance. We sought to estimate Vaccine Effectiveness (VE) for this season using available surveillance data from hospitals (including both inpatients and outpatients).MethodsSwab samples were sent by hospital physicians to one of three laboratories, covering the entire country, to be tested for influenza using RT-PCR. The test-negative design was employed, with patients testing positive serving as cases and those testing negative serving as controls. VE was estimated using logistic regression, adjusted for age group, sex, region and calendar time, with further adjustment for unknown vaccination status using inverse response propensity weights. Additional age group stratified estimates and subgroup estimates of VE against H1N1pdm09 and H3N2 were calculated.ResultsOut of 1310 patients with known vaccination status, 124 (9.5%) were vaccinated, and 543 patients (41.5%) tested positive for influenza. Adjusted VE was 34.5% (95% CI: 4.1–55.3%) against any influenza, and 56.7% (95% CI: 22.8–75.7%) against H1N1pdm09. VE estimates appeared to be higher for people aged 60 and older, while in those under 60 there was limited evidence of effectiveness. Isolated circulating strains were genetically close to the vaccine strain, with limited evidence of antigenic drift.ConclusionsThese results suggest a moderate protective effect of the 2013–2014 influenza vaccine, mainly against H1N1pdm09 and in people aged 60 and over. Vaccine coverage was very low in Greece, even among groups targeted for vaccination, and substantial efforts should be made to improve it. VE can and should be routinely monitored, and the results taken into account when deciding on influenza vaccine composition for next season. 相似文献
50.
Desmond A. Brown Benjamin T. Himes Brittny T. Major Benjamin F. Mundell Ravi Kumar Bruce Kall Fredric B. Meyer Michael J. Link Bruce E. Pollock John D. Atkinson Jamie J. Van Gompel W. Richard Marsh Giuseppe Lanzino Mohamad Bydon Ian F. Parney 《Mayo Clinic proceedings. Mayo Clinic》2018,93(1):16-24